GeoVax Labs (GOVXW) News Today

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

$0.05

0.00 (0.00%)

(As of 04/18/2024 ET)

Stock Analysis Chart Competitors Financials Headlines SEC Filings Short Interest Social Media

Source

Source	Headline
	GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine finance.yahoo.com - April 4 at 1:25 PM
	GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress finance.yahoo.com - March 28 at 9:06 AM
	GeoVax Announces Multiple Patent Issuances and Allowances finance.yahoo.com - February 13 at 10:08 AM
	GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster finance.yahoo.com - February 6 at 9:55 AM
	marketbeat.com - January 31 at 6:08 AM
	GeoVax, Inc.: GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement finanznachrichten.de - January 29 at 12:22 PM
	EQS-News: GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement markets.businessinsider.com - January 29 at 12:22 PM
	GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement finance.yahoo.com - January 29 at 12:22 PM
	GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients finance.yahoo.com - January 4 at 9:38 AM
	GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024 finance.yahoo.com - December 27 at 10:06 AM
	GeoVax, Inc.: GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox finanznachrichten.de - December 19 at 12:24 PM
	GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox finance.yahoo.com - December 19 at 12:24 PM
	Progress on GeoVax’s Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023 finance.yahoo.com - November 14 at 9:23 AM
	GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update finance.yahoo.com - November 8 at 6:49 PM
	GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine finance.yahoo.com - October 30 at 11:43 AM
	GeoVax to Participate in Upcoming November Investor and Industry Events finance.yahoo.com - October 25 at 10:07 AM
	GeoVax Receives Notice of Allowance for Marburg Vaccine Patent finance.yahoo.com - October 9 at 10:35 AM
	GeoVax Receives Notice of Allowance for HIV Vaccine Patent finance.yahoo.com - October 5 at 9:54 AM
	GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development finance.yahoo.com - September 26 at 10:29 AM
	GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference finance.yahoo.com - September 20 at 10:01 AM
	GeoVax to Present at the Emerging Growth Conference on September 6, 2023 finance.yahoo.com - August 29 at 2:58 PM
	GeoVax Announces First Patients Vaccinated in Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia finance.yahoo.com - August 10 at 9:02 AM
	GeoVax Reports 2023 Second Quarter Financial Results and Provides Corporate Update finance.yahoo.com - August 9 at 7:43 PM
	GeoVax Labs Shares Rise 8% After Patent for Ebola Vaccine marketwatch.com - July 24 at 12:21 PM
	GOVX - GeoVax Labs, Inc. finance.yahoo.com - July 11 at 11:25 PM
	GeoVax Presents Gedeptin® Clinical Data at the AACR-AHNS Head and Neck Cancer Conference finance.yahoo.com - July 10 at 9:49 AM
	GeoVax’s Next-Generation COVID-19 Vaccine Shows High Immunogenicity in Immunocompromised Patients finance.yahoo.com - May 24 at 8:10 AM
	GeoVax Labs to Participate in A.G.P.’s Virtual Healthcare Conference finance.yahoo.com - May 9 at 9:49 AM
	Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX), Selecta Biosciences (SELB) and Assembly Biosciences (ASMB) markets.businessinsider.com - May 8 at 8:21 AM
	GeoVax to Participate in the 4th Symposium on Infectious Diseases in the Immunocompromised Host finance.yahoo.com - April 26 at 9:40 AM
	GeoVax to Host First Quarter 2023 Business Update and Financial Results Conference Call on May 4, 2023 finance.yahoo.com - April 25 at 12:43 PM
	GeoVax, Inc.: GeoVax Announces Presentation of Preliminary Data from Clinical Trial of Next-Generation COVID-19 Vaccine Candidate finanznachrichten.de - April 6 at 1:23 PM
	GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2022 Earnings Call Transcript finance.yahoo.com - March 27 at 7:33 AM
	GeoVax, Inc.: GeoVax Reports 2022 Year-End Financial Results and Provides Corporate Update finanznachrichten.de - March 24 at 10:10 AM
	GeoVax Announces Decisive Progress in Establishing High-Capacity, Continuous Cell Line System to Manufacture MVA-based Vaccines finance.yahoo.com - February 8 at 9:33 AM
	GeoVax Reports 2022 Third Quarter Financial Results and Provides Corporate Update finance.yahoo.com - November 9 at 4:59 PM
	GeoVax to Host Third Quarter 2022 Business Update and Financial Results Conference Call on November 9, 2022 finance.yahoo.com - October 26 at 9:46 AM
	GeoVax to Present at Vaccines Summit-2022 finance.yahoo.com - October 11 at 10:36 AM
	GeoVax: Possible Vaccine Advancements In 2 Big Indications seekingalpha.com - August 10 at 7:09 PM
	GeoVax Labs, Inc. (GOVX) CEO David A. Dodd on Q2 2022 Results - Earnings Call Transcript seekingalpha.com - August 3 at 10:20 PM
	GeoVax Reports 2022 Second Quarter Financial Results and Provides Corporate Update finance.yahoo.com - August 3 at 5:20 PM
	GeoVax Labs Shares Rise 13% After Positive Study Results for Ebolavirus Vaccine marketwatch.com - July 30 at 3:55 AM
	GeoVax Labs Gains Another 47% marketwatch.com - July 27 at 2:29 PM

Get GeoVax Labs News Delivered to You Automatically

You’re invited: Biggest crypto event of 2024 (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

GOVXW Media Mentions By Week

GOVXW Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GOVXW
News Sentiment
▼
0.00

0.53
▲
Average
Medical
News Sentiment

GOVXW News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GOVXW Articles
This Week
▼
0

0
▲
GOVXW Articles
Average Week

Get GeoVax Labs News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:GOVXW) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

GeoVax Labs (GOVXW) News Today

GOVXW Media Mentions By Week

GOVXW Media Sentiment

GOVXW News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info